BioCardia(BCDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BCDA BioCardia

未开盘 11-21 16:00:00 EST

2.14

+0.15

+7.29%

盘后2.14

+0.000.00%

16:44 EST

最高2.15	最低1.98	成交量3.74万
今开2.04	昨收1.99	日振幅8.54%
总市值978.75万	流通市值793.11万	总股本458.43万
成交额7.83万	换手率1.01%	流通股本371.48万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BCDA","market":"US","secType":"STK","nameCN":"BioCardia","latestPrice":2.135,"timestamp":1732222800000,"preClose":1.99,"halted":0,"volume":37371,"hourTrading":{"tag":"盘后","latestPrice":2.135,"preClose":2.135,"latestTime":"16:44 EST","volume":50,"amount":110,"timestamp":1732225478697},"delay":0,"floatShares":3714800,"shares":4584300,"eps":-5.269979,"marketStatus":"未开盘","marketStatusCode":0,"change":0.145,"latestTime":"11-21 16:00:00 EST","open":2.04,"high":2.15,"low":1.98,"amount":78279.239892,"amplitude":0.085427,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.269979,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"adjPreClose":1.99,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.01,"preClose":1.99,"latestTime":"09:06 EST","volume":249,"amount":499.10996730000005,"timestamp":1732197973213},"postHourTrading":{"tag":"盘后","latestPrice":2.135,"preClose":2.135,"latestTime":"16:44 EST","volume":50,"amount":110,"timestamp":1732225478697},"volumeRatio":0.54069,"impliedVol":0.8044,"impliedVolPercentile":0.5606},"requestUrl":"/m/hq/s/BCDA","defaultTab":"news","newsList":[{"id":"2485497652","title":"Biocardia, Inc.盘中异动 快速上涨5.02%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497652?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:40","pubTimestamp":1732200002,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时40分，Biocardia, Inc.股票出现波动，股价大幅拉升5.02%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224002971a7e30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224002971a7e30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2484117446","title":"Biocardia, Inc.盘中异动 股价大涨7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484117446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484117446?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:35","pubTimestamp":1732113322,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时35分，Biocardia, Inc.股票出现异动，股价大幅拉升7.38%。Biocardia, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp、Tonix Pharmaceuticals Holding Corp.涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为533.98%、184.85%、109.51%，振幅较大的相关个股有Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为39.57%、30.55%、23.42%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022352298e43bdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022352298e43bdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2484745306","title":"Biocardia, Inc.盘中异动 急速拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484745306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484745306?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:13","pubTimestamp":1731942794,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时13分，Biocardia, Inc.股票出现波动，股价快速上涨5.40%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为555.13%、509.31%、338.19%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.81%、75.18%、73.24%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231314a2433ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118231314a2433ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2483835386","title":"Biocardia, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483835386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483835386?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:06","pubTimestamp":1731600374,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时06分，Biocardia, Inc.股票出现异动，股价大幅下跌5.11%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药、Pulmatrix, Inc.涨幅较大，Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为2849.28%、306.00%、41.49%，振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药，振幅分别为112.92%、86.36%、73.75%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000614abc18dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000614abc18dd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2483089266","title":"BioCardia Inc 报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483089266","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483089266?lang=zh_cn&edition=full","pubTime":"2024-11-14 12:03","pubTimestamp":1731557039,"startTime":"0","endTime":"0","summary":"BioCardia Inc 报告本季度业绩 - 收益摘要BioCardia Inc BCDA.OQ公布的季度调整后每股亏损61美分，高于去年同期的每股收益1.80美元。报告收入为零，分析师预期为 20 万美元。BioCardia Inc 报告的本季度每股收益为亏损 61 美分。该公司当季亏损 174 万美元。BioCardia Inc 的股价本季度下跌了 23.1%，今年迄今为止下跌了 75.9%。华尔街对 BioCardia Inc 的 12 个月目标价中位数为 25.00 本摘要由 LSEG 11 月 14 日上午 04:03 时的调制解调器器生成。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML0D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2483080571","title":"Biocardia, Inc.盘中异动 早盘股价大涨6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483080571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483080571?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:36","pubTimestamp":1731425815,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时36分，Biocardia, Inc.股票出现异动，股价急速上涨6.45%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112233655971a60ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112233655971a60ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2482910714","title":"BioCardia Inc 预计每股亏损1.19美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482910714","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482910714?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:47","pubTimestamp":1731383250,"startTime":"0","endTime":"0","summary":"BioCardia Inc 预计每股亏损1.19美元 - 财报前瞻BioCardia Inc BCDA.OQ BCDA.O预计将在11月13日公布截至2024年9月30日的季度收入报告。根据LSEG的数据，一位分析师预计这家总部位于加利福尼亚桑尼维尔的公司的营收将从一年前的35.7万美元下降44.0%至20万美元。LSEG 的分析师平均预计 BioCardia Inc 每股亏损 1.19 美元。华尔街对 BioCardia Inc 的 12 个月目标价中位数为 25.00 美元，高于其最新收盘价 2.30 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4T3MJ0C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"gpt_icon":0},{"id":"2480809615","title":"BioCardia Inc   预计每股亏损1.19美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480809615","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480809615?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:42","pubTimestamp":1730734943,"startTime":"0","endTime":"0","summary":"   * BioCardia Inc    预计将在11月6日公布截至2024年9月30日的业绩报告(估计)，季度收入将出现下降。* 根据LSEG的数据，一位分析师预计这家总部位于加利福尼亚桑尼维尔的公司的营收将从一年前的35.7万美元下降44.0%至20万美元。* LSEG 的分析师平均预计 BioCardia Inc 每股亏损 1.19 美元。* 华尔街对 BioCardia Inc 的 12 个月目标价中位数为 25.00 美元，高于其最新收盘价 2.39 美元。11月4日 - 本摘要于北京时间 11 月 4 日 15:41 机器生成。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"BioCardia Inc   预计每股亏损1.19美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"gpt_icon":0},{"id":"2479239024","title":"Biocardia, Inc.盘中异动 大幅下挫7.22%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479239024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479239024?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:51","pubTimestamp":1730220719,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时51分，Biocardia, Inc.股票出现波动，股价大幅下挫7.22%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Dermata Therapeutics Inc C/Wts 涨幅较大，Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1338.42%、1237.64%、331.24%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为183.65%、88.24%、78.31%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030005159a1f6238a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030005159a1f6238a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2477463538","title":"Biocardia, Inc.盘中异动 大幅拉升6.15%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477463538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477463538?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:34","pubTimestamp":1729690456,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时34分，Biocardia, Inc.股票出现异动，股价大幅拉升6.15%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Dbv Technologies涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为989.87%、530.86%、279.18%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.，振幅分别为42.95%、28.57%、23.60%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213417ab6d6fda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213417ab6d6fda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2477866646","title":"Biocardia, Inc.盘中异动 早盘大幅上涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866646?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:51","pubTimestamp":1729518695,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时51分，Biocardia, Inc.股票出现异动，股价急速拉升5.58%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.较为活跃，换手率分别为2152.19%、1454.50%、525.70%，振幅较大的相关个股有Genprex, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Gri Bio, Inc.，振幅分别为176.03%、116.08%、91.38%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121513598e3d88b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121513598e3d88b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2475919637","title":"Biocardia, Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475919637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475919637?lang=zh_cn&edition=full","pubTime":"2024-10-16 00:17","pubTimestamp":1729009069,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日00时17分，Biocardia, Inc.股票出现波动，股价急速下跌5.41%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Bright Minds Biosciences Inc.、Apollomics Inc C/Wts 01/04/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Bright Minds Biosciences Inc.、Salarius Pharmaceuticals, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为1446.49%、380.92%、335.97%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为587.55%、165.96%、123.44%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016001749a1e0dc14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016001749a1e0dc14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2474749319","title":"Biocardia, Inc.盘中异动 股价大涨8.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474749319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474749319?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:30","pubTimestamp":1728567033,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时30分，Biocardia, Inc.股票出现波动，股价快速拉升8.12%。Biocardia, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为102.66%、102.35%、98.26%，振幅较大的相关个股有Biocardia, Inc.、Vaccinex, Inc.、Clearmind Medicine Inc.，振幅分别为8.49%、7.78%、5.71%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021303398e3bb57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021303398e3bb57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2473002411","title":"Biocardia, Inc.盘中异动 临近午盘急速下跌5.11%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473002411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473002411?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:34","pubTimestamp":1728315266,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时34分，Biocardia, Inc.股票出现异动，股价大幅下跌5.11%。截至发稿，该股报2.60美元/股，成交量1.8471万股，换手率0.53%，振幅5.11%。Biocardia, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100723342698e3ae46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100723342698e3ae46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2472252628","title":"Biocardia, Inc.盘中异动 早盘股价大跌5.03%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472252628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472252628?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:48","pubTimestamp":1727876906,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时48分，Biocardia, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报2.83美元/股，成交量4524股，换手率0.13%，振幅1.67%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002214826ab677602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002214826ab677602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2472344523","title":"Biocardia, Inc.盘中异动 下午盘大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472344523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472344523?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:25","pubTimestamp":1727717139,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时25分，Biocardia, Inc.股票出现异动，股价急速上涨5.10%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Nkgen Biotech Inc C/Wts 31/05/2028、Capricor Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Gri Bio, Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为166.09%、56.10%、55.81%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Tc Biopharm  Plc C/Wts 10/02/2028 、Capricor Therapeutics, Inc.，振幅分别为87.30%、85.25%、45.53%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001012539a1ddbbe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001012539a1ddbbe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2470035884","title":"Biocardia, Inc.盘中异动 急速上涨5.07%报2.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470035884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470035884?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:37","pubTimestamp":1727451475,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时37分，Biocardia, Inc.股票出现异动，股价急速拉升5.07%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927233755a1dd1595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927233755a1dd1595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2470261276","title":"Biocardia, Inc.盘中异动 早盘大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470261276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470261276?lang=zh_cn&edition=full","pubTime":"2024-09-25 23:23","pubTimestamp":1727277798,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日23时23分，Biocardia, Inc.股票出现异动，股价急速拉升5.19%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092523231898e38e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092523231898e38e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2469494369","title":"Biocardia, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469494369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469494369?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:43","pubTimestamp":1727185438,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时43分，Biocardia, Inc.股票出现异动，股价快速跳水5.26%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Onconetix, Inc.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为1413.30%、154.45%、23.88%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Onconetix, Inc.、Capricor Therapeutics, Inc.，振幅分别为59.63%、38.68%、28.22%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924214358a1dc375d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924214358a1dc375d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2469114962","title":"Biocardia, Inc.盘中异动 早盘大幅上涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469114962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469114962?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:32","pubTimestamp":1727098334,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时32分，Biocardia, Inc.股票出现波动，股价大幅上涨6.10%。Biocardia, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Pharmacyte  Biotech, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Black Diamond Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为37.83%、25.94%、22.60%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、Galmed Pharmaceuticals Ltd.、天演药业，振幅分别为18.52%、16.05%、13.14%。Biocardia, Inc.公司简介：BioCardia Inc 是一家临床阶段公司，开发细胞和细胞衍生疗法，用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213214a1dbec36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213214a1dbec36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":0.0596},{"period":"1month","weight":-0.1788},{"period":"3month","weight":-0.1426},{"period":"6month","weight":-0.5886},{"period":"1year","weight":-0.7805},{"period":"ytd","weight":-0.7857}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biocardia, Inc.于1994年1月12日在特拉华州注册成立。该公司是一家临床阶段的再生医学公司，为具有大量未满足的医疗需求的心血管疾病开发新的治疗药物。他们的主要治疗候选药物是研究性CardiAMP细胞治疗系统，该系统提供自体骨髓衍生细胞疗法（使用患者自身细胞）治疗两种临床适应症：心脏病发作和慢性心肌缺血后发生的心力衰竭。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.06938},{"month":2,"riseRate":0.5,"avgChangeRate":-0.000116},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.063445},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.020094},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.051537},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.041157},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.032675},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.106569},{"month":9,"riseRate":0.428571,"avgChangeRate":0.059679},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.068561},{"month":11,"riseRate":0.428571,"avgChangeRate":0.034676},{"month":12,"riseRate":0.5,"avgChangeRate":0.01405}],"exchange":"NASDAQ","name":"BioCardia","nameEN":"BioCardia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCardia(BCDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioCardia(BCDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioCardia,BCDA,BioCardia股票,BioCardia股票老虎,BioCardia股票老虎国际,BioCardia行情,BioCardia股票行情,BioCardia股价,BioCardia股市,BioCardia股票价格,BioCardia股票交易,BioCardia股票购买,BioCardia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCardia(BCDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioCardia(BCDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}